Objectives: Because both breast cancer and the hormone leptin are associate
d with obesity and reproductive phenomena in women, we have examined whethe
r there is a relationship between leptin and breast cancer among premenopau
sal and postmenopausal women. We have also evaluated in this dataset the as
sociation of IGF-I with breast cancer.
Methods: Seventy-five cases, diagnosed during mammographic screening, with
incident breast cancer were matched for age and type of permanent residence
with seventy-five controls from those screened negative in the same study
base.
Results: There was no evidence for an association between IGF-I and either
premenopausal or postmenopausal breast cancer risk or between leptin and po
stmenopausal breast cancer. Among premenopausal women, however, there was a
strong and statistically significant inverse association of leptin with br
east cancer.
Conclusion: We did not confirm the positive association, reported from othe
r investigations, of IGF-I with premenopausal breast cancer risk. We have f
ound evidence, however, that leptin may be inversely related to breast canc
er risk among premenopausal women. The latter finding is not biologically i
mplausible and deserves to be examined in additional datasets.